Skip to search formSkip to main contentSkip to account menu

anti-cyclic citrullinated peptide

Known as: anti cyclic citrullinated peptide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
P023 Smoking is associated with low serum levels of soluble PD-l1 in rheumatoid arthritis
Introduction Smoking is a risk factor for the development of rheumatoid arthritis (RA) and associates with positivity for disease… 
2017
2017
Diagnosis and management of rheumatoid arthritis
Early recognition and treatment of rheumatoid arthritis is the key to a more successful outcome. This article discusses the… 
2016
2016
AB0188 Effect of Smoking on Joint Damage and Disease Activity in Patients with Rheumatoid Arthritis
Background It is known that smoking is a poor prognostic factor for the development of rheumatoid arthritis (RA) and other… 
2015
2015
AB0273 Methylentetrahydrofolate Reductase C677T Gene Polymorphism is Associated with Progressive Joint Destruction and Anti- Cyclic Citrullinated Peptide (ACCP) Positivity in Patients with Early…
Background The recent evidence suggests that clinical effectiveness of methotrexate might not be always accompanied by slowing… 
2013
2013
Anti-Sa Antibody, Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor As Diagnostic Markers Of Rheumatoid Arthritis
Citrullinated peptide Antibodies are novel diagnostic markers for Rheumatoid Arthritis (RA).Anti-Sa Antibody is one of the… 
2013
2013
[Anticitrulin antibody and the extra-articular manifestations in rheumatoid arthritis].
A large proportion of rheumatoid arthritis (RA) patients develop extra-articular manifestations (EAM), which are associated with… 
2013
2013
Anticuerpo anticitrulina y manifestaciones extra articulares en artritis reumatoidea
Anticitrulin antibody and the extra-articular manifestations in rheumatoid arthritis. A large proportion of rheumatoid arthritis… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)